An Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
An Chen has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Chuanmin Hu
College of Marine Science, University of South Florida, St. Petersburg, FL, USA
1 shared publication - Dong Liu
Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication - Dun Niu
Department of Clinical Biochemistry, Faculty of Pharmacy and Laboratory Medicine, Army Medical University, Chongqing, China
1 shared publication - Fanwei Meng
Academy of Laboratory, Jilin Medical University, Jilin, PR China
1 shared publication Fengtian He
Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University, Chongqing, China
1 shared publication- Fengtian He
Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication
Latest Publications
- 8 July 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 450 (2) , 114669
“TFEB–HNRNPA2B1”: A positive feedback loop facilitating metastasis in hepatocellular carcinoma cells
- 8 July 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 450 (2) , 114669
“TFEB–HNRNPA2B1”: A positive feedback loop facilitating metastasis in hepatocellular carcinoma cells
- 8 March 2024
- Published by Taylor & Francis in Autophagy
- Vol. 20 (7) , 1651-1672
Lopinavir enhances anoikis by remodeling autophagy in a circRNA-dependent manner
- 8 March 2024
- Published by Taylor & Francis in Autophagy
- Vol. 20 (7) , 1651-1672
Lopinavir enhances anoikis by remodeling autophagy in a circRNA-dependent manner
- Open Access
- 1 March 2020
- Published by Elsevier in SLAS Discovery
- Vol. 25 (3) , 310-319
Generation of a Monoclonal Antibody against D-Dimer Using HTS-Based LiCA
- 1 March 2020
- Published by Elsevier in SLAS Discovery
- Vol. 25 (3) , 310-319
Open AccessGeneration of a Monoclonal Antibody against D-Dimer Using HTS-Based LiCA
- Open Access
- 1 May 2005
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (9) , 5568-5576
H-2 Kd-Restricted Hepatitis B Virus-Derived Epitope Whose Specific CD8+T Lymphocytes Can Produce Gamma Interferon without Cytotoxicity
It is necessary to evaluate the cytokine secretion status of CD8+T lymphocytes and elucidate the factors influencing cytokine secretion, because the secretion of cytokines is also an important feature of CD8+T lymphocytes, and the cytokines usually play critical roles in the outcome of diseases. We showed here that peptide AYRPPNAPI, derived from the core antigen of hepatitis B virus (HBV), could bind to H-2 Kdand induce primed splenocytes from HBcAg expression plasmid-immunized mice to produce gamma interferon (IFN-γ) in H-2 Kd- and CD8-dependent manners instead of in a CD4-dependent manner. The induced cells were mainly CD3 and CD8 positive but had no cytotoxic effect on the corresponding target cells. When administered into HBV transgenic mice, these cells can decrease the serum HBV load without causing liver damage. These results suggest that this peptide is a special kind of CD8+T-cell epitope, for which specific CD8+T cells can produce IFN-γ when antigenic stimulation is encountered but which have no cytotoxic effect on the corresponding target cells both in vitro and in HBV transgenic mice. This phenomenon indicates initially that the functional mechanisms of CD8+T cells can be determined by their epitope specificity, which may be associated with the development of epitope-based immunotherapeutic approaches for infectious diseases and tumors.
- 1 May 2005
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (9) , 5568-5576
Open AccessH-2 Kd-Restricted Hepatitis B Virus-Derived Epitope Whose Specific CD8+T Lymphocytes Can Produce Gamma Interferon without Cytotoxicity
It is necessary to evaluate the cytokine secretion status of CD8+T lymphocytes and elucidate the factors influencing cytokine secretion, because the secretion of cytokines is also an important feature of CD8+T lymphocytes, and the cytokines usually play critical roles in the outcome of diseases. We showed here that peptide AYRPPNAPI, derived from the core antigen of hepatitis B virus (HBV), could bind to H-2 Kdand induce primed splenocytes from HBcAg expression plasmid-immunized mice to produce gamma interferon (IFN-γ) in H-2 Kd- and CD8-dependent manners instead of in a CD4-dependent manner. The induced cells were mainly CD3 and CD8 positive but had no cytotoxic effect on the corresponding target cells. When administered into HBV transgenic mice, these cells can decrease the serum HBV load without causing liver damage. These results suggest that this peptide is a special kind of CD8+T-cell epitope, for which specific CD8+T cells can produce IFN-γ when antigenic stimulation is encountered but which have no cytotoxic effect on the corresponding target cells both in vitro and in HBV transgenic mice. This phenomenon indicates initially that the functional mechanisms of CD8+T cells can be determined by their epitope specificity, which may be associated with the development of epitope-based immunotherapeutic approaches for infectious diseases and tumors.